BioTech News at Arizona Biotech

Biotech News <<< Mailing List

Biotechnology News <<< Discussion Forums

Thursday, September 15, 2005
 
Biotech Stocks: Biopharma indexes diverge, Dendreon soars - Biotechnology - Pharmaceuticals - Stock Reports - Market News
Biotech Stocks: Biopharma indexes diverge, Dendreon soars - Biotechnology - Pharmaceuticals - Stock Reports - Market News

BIOTECH STOCKS

Biopharma indexes diverge, Dendreon soars

By Val Brickates Kennedy, MarketWatch

BOSTON (MarketWatch)-The benchmark sector indexes diverged on Wednesday while shares of Dendreon staged a late-day rally on positive news for its drug Provenge.

The Amex Biotechnology Index

Dendreon (DNDN: news, chart, profile) shot up 13%

Celgene (CELG: news, chart, profile) shares rose 4% to $54.77, after being halted

An advisory panel of the Food and Drug Administration voted midday to recommend Revlimid be approved to treat a type of anemia caused by myelodysplastic syndromes, a group of diseases that cripple the body's ability to make healthy blood cells.

Progenics Pharmaceuticals

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech

Comments: Post a Comment

<< Home

Powered by Blogger